DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2026
    • Delegate Registration
    • Lecture Programme
    • Speakers
    • The DDL Incubator
    • Attending Exhibitors and Sponsors
    • Exhibition & Sponsorship Opportunities
    • New Researcher Network
    • Hotel and Travel
    • Media Partners
    • Frequently Asked Questions
  • Archive
    • Conference Papers Archive
    • DDL2025
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • EPAG Workshop
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2024
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2023
      • Lecture Recordings
      • The Association of Inhalation Toxicologists – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2022
      • Lecture Recordings
      • Academy of Pharmaceutical Sciences – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2021
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Sponsors
    • Previous Years Conferences
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • The Scientific Advisors
    • Contact
  • Associated Events
    • Annual Aerosol Science Conference
    • RDD 2027
  • The Aerosol Society logo
Dr Gonçalo Farias

Dr Gonçalo Farias

Aptar Pharma

Gonçalo Farias is heading the analytical and innovation Hub at Aptar Pharma in France. Gonçalo holds a Master’s degree in Pharmaceutical Sciences from the University of Lisbon and a PhD in Pharmacy and Pharmacology from the University of Bath. During his doctoral studies, he specialised in the design and characterisation of orally inhaled and nasal drug products, with several publications in peer-reviewed journals.
He brings over 10 years of experience in the development of complex orally inhaled and nasal drug products, with experience in analytical sciences, formulation, and device–product integration. His current work focuses on advancing innovative nasal drug delivery technologies.

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2026 Drug Delivery to the Lungs Website design: definingdesign.co.uk